IFS
IMNP

Ifrah Financial Services’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Ifrah Financial Services’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-650
Closed -$4K – 206
2016
Q3 		$4K Hold
650
– – ﹤0.01% 191
2016
Q2 		$5K Hold
650
– – ﹤0.01% 195
2016
Q1 		$6K Sell
650
-100
-13% -$1.03K ﹤0.01% 192
2015
Q4 		$11K Sell
750
-348
-32% -$7.31K ﹤0.01% 188
2015
Q3 		$26K Hold
1,098
– – 0.01% 194
2015
Q2 		$42K Hold
1,098
– – 0.02% 201
2015
Q1 		$39K Buy
1,098
+50
+5% +$1.87K 0.01% 202
2014
Q4 		$40K Buy
+1,048
New +$56.3K 0.02% 197

Other funds holding IMNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Ifrah Financial Services's IMNP Position: Q4 2016 in Review

Ifrah Financial Services sold out of Immune Pharmaceuticals Inc. (IMNP) in Q4 2016, closing a stake of 650 shares — an estimated $4K sold.

Ifrah Financial Services first reported a position in IMNP in Q4 2014 and held it in 8 quarters. The position peaked at $42K in Q2 2015. 14 funds tracked by Wall St. Rank hold IMNP as of Q4 2016.

  • Ifrah Financial Services reported no remaining Immune Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
  • Ifrah Financial Services sold 650 Immune Pharmaceuticals Inc. shares in Q4 2016, an estimated $4K.
  • Ifrah Financial Services first reported a position in Immune Pharmaceuticals Inc. in Q4 2014 and held it in 8 quarters.
  • Ifrah Financial Services's Immune Pharmaceuticals Inc. position peaked at $42K in Q2 2015.
  • 14 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q4 2016.

Based on Ifrah Financial Services's 13F filing for Q4 2016, filed 8 Feb 2017.